✦ LIBER ✦

Modulation of CD20 antigen expression after rituximab treatment: A retrospective study in patients with chronic lymphocytic leukemia

✍ Scribed by Fiorella D’Auria; Roberto Guariglia; Oreste Villani; Giovanna Mansueto; Vitina Grieco; Antonia Zonno; Gabriella Bianchino; Luigina Di Giovannantonio; Giulia Vita; Pellegrino Musto

Book ID: 113544299
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 94 KB
Volume: 32
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2010.10.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chronic lymphocytic leukemia-associated

Chronic lymphocytic leukemia-associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patients

✍ Giovanni D’Arena; Silvana Capalbo; Luca Laurenti; Giovanni Del Poeta; Giuseppe N 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Effects of cytokines on CD20 antigen exp

Effects of cytokines on CD20 antigen expression on tumor cells from patients with chronic lymphocytic leukemia

✍ Parameswaran Venugopal; Smitha Sivaraman; Xiao-Ke Huang; Jaya Nayini; Stephanie 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 120 KB

A phase I/II study of rituximab and etan

A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma

✍ Lin, T S; Lucas, M S; Heerema, N; Moran, M E; Cheney, C; Woyach, J A; Lucas, D M 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 160 KB

Bendamustine in Combination With Rituxim

Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

✍ Fischer, K.; Cramer, P.; Busch, R.; Bottcher, S.; Bahlo, J.; Schubert, J.; Pflug 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 156 KB

The successful treatment of refractory a

The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia

✍ Gülsüm Emel Pamuk; Burhan Turgut; Muzaffer Demir; Fatma Tezcan; Özden Vural 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

Circulating CD52 and CD20 levels at end

Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR)

✍ Gheath Alatrash; Maher Albitar; Susan O’Brien; Xuemei Wang; Taghi Manshouri; Ste 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB